Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial

医学 冲程(发动机) 打开标签 急性中风 随机对照试验 临床试验 血管内治疗 缺血性中风 内科学 外科 组织纤溶酶原激活剂 缺血 动脉瘤 机械工程 工程类
作者
Martin Bendszus,Jens Fiehler,Fabien Subtil,Susanne Bonekamp,Anne Hege Aamodt,Blanca Fuentes,Elke R. Gizewski,Michael D. Hill,Antonı́n Krajina,Laurent Pierot,Claus Z. Simonsen,Kamil Zeleňák,Rolf Ankerlund Blauenfeldt,Bastian Cheng,Angélique Denis,Hannes Deutschmann,Franziska Dorn,Fabian Flottmann,Susanne Gellißen,Johannes Gerber
出处
期刊:The Lancet [Elsevier BV]
卷期号:402 (10414): 1753-1763 被引量:295
标识
DOI:10.1016/s0140-6736(23)02032-9
摘要

Summary

Background

Recent evidence suggests a beneficial effect of endovascular thrombectomy in acute ischaemic stroke with large infarct; however, previous trials have relied on multimodal brain imaging, whereas non-contrast CT is mostly used in clinical practice.

Methods

In a prospective multicentre, open-label, randomised trial, patients with acute ischaemic stroke due to large vessel occlusion in the anterior circulation and a large established infarct indicated by an Alberta Stroke Program Early Computed Tomographic Score (ASPECTS) of 3–5 were randomly assigned using a central, web-based system (using a 1:1 ratio) to receive either endovascular thrombectomy with medical treatment or medical treatment (ie, standard of care) alone up to 12 h from stroke onset. The study was conducted in 40 hospitals in Europe and one site in Canada. The primary outcome was functional outcome across the entire range of the modified Rankin Scale at 90 days, assessed by investigators masked to treatment assignment. The primary analysis was done in the intention-to-treat population. Safety endpoints included mortality and rates of symptomatic intracranial haemorrhage and were analysed in the safety population, which included all patients based on the treatment they received. This trial is registered with ClinicalTrials.gov, NCT03094715.

Findings

From July 17, 2018, to Feb 21, 2023, 253 patients were randomly assigned, with 125 patients assigned to endovascular thrombectomy and 128 to medical treatment alone. The trial was stopped early for efficacy after the first pre-planned interim analysis. At 90 days, endovascular thrombectomy was associated with a shift in the distribution of scores on the modified Rankin Scale towards better outcome (adjusted common OR 2·58 [95% CI 1·60–4·15]; p=0·0001) and with lower mortality (hazard ratio 0·67 [95% CI 0·46–0·98]; p=0·038). Symptomatic intracranial haemorrhage occurred in seven (6%) patients with thrombectomy and in six (5%) with medical treatment alone.

Interpretation

Endovascular thrombectomy was associated with improved functional outcome and lower mortality in patients with acute ischaemic stroke from large vessel occlusion with established large infarct in a setting using non-contrast CT as the predominant imaging modality for patient selection.

Funding

EU Horizon 2020.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小新应助彩色的芝麻采纳,获得10
刚刚
张乐乐关注了科研通微信公众号
1秒前
十九世纪发布了新的文献求助10
1秒前
缓慢钢笔发布了新的文献求助10
1秒前
Mr朱发布了新的文献求助10
1秒前
lw发布了新的文献求助10
2秒前
Franco完成签到,获得积分10
2秒前
2秒前
小二郎应助lu采纳,获得10
3秒前
3秒前
4秒前
goftmac完成签到,获得积分10
4秒前
Lucas应助可乐采纳,获得10
4秒前
科研通AI6应助楚乐倩采纳,获得10
5秒前
小青椒应助忧伤的觅珍采纳,获得60
5秒前
orixero应助fa采纳,获得10
5秒前
6秒前
7秒前
宁馨明发布了新的文献求助50
7秒前
量子星尘发布了新的文献求助10
7秒前
小杭76应助yz采纳,获得10
7秒前
2240920060发布了新的文献求助10
7秒前
科研通AI5应助小菇凉采纳,获得10
8秒前
Sugaryeah发布了新的文献求助10
9秒前
9秒前
10秒前
10秒前
小汤圆完成签到,获得积分10
10秒前
完美世界应助纯情的碧玉采纳,获得10
10秒前
10秒前
10秒前
11秒前
11秒前
12秒前
今后应助缓慢钢笔采纳,获得10
12秒前
琪凯定理发布了新的文献求助10
12秒前
胡飞发布了新的文献求助10
12秒前
喜喜喜嘻嘻嘻完成签到 ,获得积分10
12秒前
12秒前
深情安青应助阿郑采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
解放军总医院眼科医学部病例精解 1000
温州医科大学附属眼视光医院斜弱视与双眼视病例精解 1000
Zur lokalen Geoidbestimmung aus terrestrischen Messungen vertikaler Schweregradienten 1000
translating meaning 500
Storie e culture della televisione 500
Selected research on camelid physiology and nutrition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4895731
求助须知:如何正确求助?哪些是违规求助? 4177560
关于积分的说明 12968471
捐赠科研通 3940681
什么是DOI,文献DOI怎么找? 2161969
邀请新用户注册赠送积分活动 1180348
关于科研通互助平台的介绍 1085932